Lakefront Biotherapeutics American Depositary Shares
LKFT
44 hedge funds and large institutions have $518M invested in Lakefront Biotherapeutics American Depositary Shares in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 10 closing their positions.
60% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 10
41% more capital invested
Capital invested by funds: $368M → $518M (+$150M)
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
16% more funds holding
Funds holding: 38 → 44 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$14.6M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.55M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$6.43M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.25M |
| 5 |
GP
GLG Partners
London,
United Kingdom
|
+$3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$23.9M |
| 2 |
O
OrbiMed
New York
|
-$14.5M |
| 3 |
DM
Deerfield Management
New York
|
-$13.2M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.6M |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
-$7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Nomura Asset Management
Tokyo,
Japan
| – | -$407K | -10,000 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$9K | -219 | Closed |
|
53
BNP Paribas Financial Markets
Paris,
France
| – | -$81 | -2 | Closed |
|
54
Wells Fargo
San Francisco,
California
| – | +$307 | +6 | New |
|
LKFT Hedge Fund Activity: Q4 2015 in Review
44 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q4 2015, worth a combined $518M — up 41% from $368M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new LKFT positions and 10 closed out — a net gain of 6 holders — while 13 added to existing stakes and 10 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $14.6M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $23.9M sold.
- 44 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q4 2015, up from 38 in Q3 2015.
- Funds reported $518M of Lakefront Biotherapeutics American Depositary Shares stock for Q4 2015, up 41% quarter-over-quarter.
- 16 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q4 2015 and 10 closed out, a net change of +6 holders.
- The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q4 2015 was Wellington Management Group, an estimated $14.6M added.
- The largest Lakefront Biotherapeutics American Depositary Shares seller in Q4 2015 was Gilder Gagnon Howe & Co, an estimated $23.9M sold.
Based on aggregated 13F filings for Q4 2015.